Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 13/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 10/20 | 0.47 |
| ▸ | BTK | Q06187 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6199926 | 0.84 | HTR2A (0.63) | HTR2AHTR2C | |
| SCHEMBL6197004 | 0.83 | HTR2A (0.62) | HTR2AHTR2C | |
| SCHEMBL6670281 | 0.83 | HTR2A (0.71) | HTR2AHTR2CKDM4E | |
| SCHEMBL6670028 | 0.83 | HTR2A (0.71) | HTR2AHTR2C | |
| SCHEMBL6199626 | 0.83 | HTR2A (0.59) | HTR2AHTR2C | |
| SCHEMBL6222382 | 0.83 | HTR2A (0.52) | HTR2AHPGDALOX15HTR2CLPAR1 | |
| SCHEMBL6198147 | 0.82 | HTR2A (0.63) | HTR2AHTR2C | |
| SCHEMBL5063284 | 0.81 | HTR2A (0.62) | HTR2AHTR2C | |
| SCHEMBL6201617 | 0.81 | HTR2A (0.62) | HTR2AHTR2C | |
| SCHEMBL6200102 | 0.81 | HTR2A (0.59) | HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1509505-A2 | SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2005-03-02 | — | — | EP | claimed |
| WO-2003062206-A2 | SMALL MOLECULE MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2003-07-31 | — | — | WO | claimed |